Literature DB >> 12967627

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins.

Mary Donoghue1, Hiroko Wakimoto, Colin T Maguire, Susan Acton, Paul Hales, Nancy Stagliano, Victoria Fairchild-Huntress, Jian Xu, John N Lorenz, Vivek Kadambi, Charles I Berul, Roger E Breitbart.   

Abstract

Angiotensin converting enzyme related carboxypeptidase (ACE2) is a recently discovered homolog of angiotensin converting enzyme with tissue-restricted expression, including heart, and the capacity to cleave angiotensin peptides. We tested the hypothesis that cardiac ACE2 activity contributes to features of ventricular remodeling associated with the renin-angiotensin system by generating transgenic mice with increased cardiac ACE2 expression. These animals had a high incidence of sudden death that correlated with transgene expression levels. Detailed electrophysiology revealed severe, progressive conduction and rhythm disturbances with sustained ventricular tachycardia and terminal ventricular fibrillation. The gap junction proteins connexin40 and connexin43 were downregulated in the transgenic hearts, indicating that ACE2-mediated gap junction remodeling may account for the observed electrophysiologic disturbances. Spontaneous downregulation of the ACE2 transgene in surviving older animals correlated with restoration of nearly normal conduction, rhythm, and connexin expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967627     DOI: 10.1016/s0022-2828(03)00177-9

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  81 in total

Review 1.  Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.

Authors:  Lijun Shi; Caiping Mao; Zhice Xu; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-02-17       Impact factor: 7.851

Review 2.  Neural modulation of cardiac arrhythmias and sudden cardiac death.

Authors:  Douglas P Zipes; Michael Rubart
Journal:  Heart Rhythm       Date:  2006-01       Impact factor: 6.343

3.  Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression.

Authors:  Er-Liang Kong; Jin-Min Zhang; Ni An; Yong Tao; Wei-Feng Yu; Fei-Xiang Wu
Journal:  J Cell Commun Signal       Date:  2018-06-07       Impact factor: 5.782

Review 4.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 5.  Mechanisms of sudden cardiac death.

Authors:  Michael Rubart; Douglas P Zipes
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

6.  The angiotensin-(1-7)/Mas receptor axis is expressed in sinoatrial node cells of rats.

Authors:  Anderson J Ferreira; Patrícia L Moraes; Giselle Foureaux; Alexandre B Andrade; Robson A S Santos; Alvair P Almeida
Journal:  J Histochem Cytochem       Date:  2011-05-23       Impact factor: 2.479

7.  Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk.

Authors:  Nona Sotoodehnia; Guo Li; Catherine O Johnson; Rozenn N Lemaitre; Kenneth M Rice; Thomas D Rea; David S Siscovick
Journal:  Heart Rhythm       Date:  2009-06-09       Impact factor: 6.343

8.  Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.

Authors:  Yumei Feng; Huijing Xia; Yanhui Cai; Carmen M Halabi; Lenice K Becker; Robson A S Santos; Robert C Speth; Curt D Sigmund; Eric Lazartigues
Journal:  Circ Res       Date:  2009-11-19       Impact factor: 17.367

9.  The effect of amiodarone pretreatment on survival of mice with cocaine toxicity.

Authors:  Christopher R DeWitt; Nathan Cleveland; Richard C Dart; Kennon Heard
Journal:  J Med Toxicol       Date:  2005-12

Review 10.  Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.

Authors:  Matthew A Sparks; Andrew M South; Andrew D Badley; Carissa M Baker-Smith; Daniel Batlle; Biykem Bozkurt; Roberto Cattaneo; Steven D Crowley; Louis J Dell'Italia; Andria L Ford; Kathy Griendling; Susan B Gurley; Scott E Kasner; Joseph A Murray; Karl A Nath; Marc A Pfeffer; Janani Rangaswami; W Robert Taylor; Vesna D Garovic
Journal:  Hypertension       Date:  2020-09-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.